Souhaitez-vous accéder aux communiqués récents ?

Capital infusion of approximately $201 million (gross proceeds) through recent offering of convertible senior notes expected to provide cash runway into 2019New patents issued in U.S. further...

OMER, ISRAEL--(Marketwired - May 4, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization...

PRINCETON, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company today announced that data from its Phase 3 SECURE study will be presented at...

GAINESVILLE, Fla., and CAMBRIDGE, Mass., May 02, 2017 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of...

In an analysis of pooled Phase 2/3 data, ZilrettaTM (FX006) demonstrated clinically meaningful pain relief and functional improvement in patients with osteoarthritisA separate Phase 2 study shows...

ALISO VIEJO, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., today announced new data demonstrating that the proprietary SCOUT® radar localization system significantly reduces...

OMER, ISRAEL--(Marketwired - Apr 27, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization...

BURLINGTON, Mass., April 26, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the pricing of $175.0 million aggregate principal amount of 3.375% convertible senior...

LOS ANGELES, April 26, 2017 (GLOBE NEWSWIRE) -- Monteris Medical today announced new data were presented supporting the use of its NeuroBlate® System for brain lesions at the 2017 American...

BURLINGTON, Mass., April 25, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced its intention to offer, subject to market and other conditions, $125 million principal...